Benlysta

Made by

• GlaxoSmithKline

Active Ingredient

Belimumab (genetical recombination)

Prospectus

Approval date

2017/9/27

Treats

• Systemic lupus erythematosus

Dosages

• Benlysta for I.V.infusion - 16661円／瓶

• Benlysta for I.V.infusion - 54609円／瓶